SetPoint Medical Announces Data Supporting Continued Clinical Development of its Bioelectronic Device for T...Read Press Release from
October 23, 2018
SetPoint Medical created a therapy to offer
patients and providers a better alternative for
the treatment of chronic inflammatory diseases with potentially less risk and lower cost than drug therapy. SetPoint Medical’s bioelectronic system is free of routine injections or pills and may eliminate the risks and substantial cost associated with current biologic treatments.
SetPoint Medical researchers have invested
more than four years collaborating with
leading surgeons to design an implantable
MicroRegulator and positioning device.
SetPoint Medical's small, self-contained MicroRegulator generates precise electrical pulses using an integrated circuit, telemetry hardware and a rechargeable battery enclosed in a ceramic and titanium case. Physicians determine precise, automatic dosing through an iPad prescription application and patients recharge the pulse generator at their convenience using a comfortable wireless charger.
The SetPoint Medical devices and systems and/or the use of this product in a method may be covered by one or more U.S. and/or foreign patents owned or licensed by SetPoint Medical Corporation. Other patent applications are pending. This page is intended to serve as notice under 35 U.S.C. § 287(a).
INVESTIGATIONAL DEVICE DISCLAIMER: The SetPoint Medical device is an investigational device. It is currently undergoing clinical evaluation under Food and Drug Administration’s Investigational Device Exemption and is not approved for commercial use.